Non Adherence to Diabetic Medication Among Diabetic Patients, a Case Study of Dormaa Hospital Ghana
Science Journal of Public Health
Volume 5, Issue 2, March 2017, Pages: 88-97
Received: Jul. 6, 2016;
Accepted: Aug. 1, 2016;
Published: Feb. 15, 2017
Views 122 Downloads 12
Awuni Prosper Mandela Amaltinga, Department of Nursing, Nyaho Medical Center, Accra, Ghana West Africa
Today, diabetes Mellitus is one of the chronic diseases prevalence in Ghana. This study assessed the factors that contribute to non-adherence to medication among diabetic patients undergoing therapy in Dormaa Hospital. The study used convenience and purposive sampling technique to sample 130 respondents comprising 123 diabetic patients and 7 health professionals from the Dormaa Presby Hospital. A standardized questionnaire was used to collect the data. Data was coded and analyzed with Stata 12.0. Most participants (57%) had a family history of diabetes and were at age 51 and above that most people were diagnosed with the disease. The level of diabetics’ adherence to diabetic treatment regimen was satisfactory and higher (68.5%). The majority of diabetics (69.23%) visited health facilities on monthly basis for review which involves testing of blood glucose level as well. Though most of diabetics surveyed were illiterate, they were, however, knowledgeable on the importance of treatment regimen as they disclosed that treatment regimen sought to prevent progression of the disease stage to associated complications, co-morbidities, and early death. Polyuria, polydipsia, and sweating were some of the commonest sign and symptoms mentioned by the patients. The majority of the patients (57%) had no idea of the normal range of fastening blood sugar level. Finances (25.6%), forgetfulness (45.5%), busy schedules (18.2%) and poor family support (2.5%) were some factors that affect better treatment adherence. Most diabetics called for a government subsidy to the drugs, continuous health education on the diseases and family support. The study recommends a much more focused preventive healthcare services to identify risk factors and early detection. Research on the burden of chronic diseases on the health facilities should be considered in the future.
Awuni Prosper Mandela Amaltinga,
Non Adherence to Diabetic Medication Among Diabetic Patients, a Case Study of Dormaa Hospital Ghana, Science Journal of Public Health.
Vol. 5, No. 2,
2017, pp. 88-97.
Adil, M. M., Alam, A. Y., & Jaffery, T. (2005 ). Knowledge of Type 2 Diabetic Patients about their illness. JPMA, pp. 57-78.
Alan, M. (2011), The role of health beliefs in the regimen adherence and metabolic control of adolescents and adults with diabetes mellitus. J Consult Clin Psycho, pp. 139-144.
Anderson, R., Funnell, M., Burkhart, N., Gillard, M., & Nwankwo, R. 101 Tips for Behavior Change in Diabetes Education. Alexandria, VA: American Diabetes Association, 2008.
Arauz AG, S. G. (2012). Community diabetes educational intervention at the primary care level. Rev Panam Salud Publica, pp. 145-53..
Arifulla, M., John, L. J., Sreedharan, j., Muttappallymyalil, J., & Basha, a. S. (2014). Patients’ Adherence to Anti-Diabetic Medications in a Hospital at Ajman, UAE. Malays J Med Sci, volume21 Num.1, pp. 44–49.
CDC, (2011). Distribution of age at diagnosis of diabetes among adults, diabetes public health resource. Atlanta GA.
Claxton AJ, C. J. (2009). A systematic review of the associations between dose regimens and medication compliance. Clin Ther volume23 Num.(8), pp. 1296-1310.
Claxton AJ. (2009). A systematic review of the association between dose. BMJ VOL66, pp. 45-78.
Delamater, A. M. (2006). Improving Patient Adherence. Clinical Diabetes vol. 24, pp. 71-77.
Glasgow RE, T. D. (2009). Social environment and regimen adherence among type II diabetic patients. Diabetes Care volume 11, pp. 377-386.
Harris MI, C. C. (1993). Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care volume 16, pp. 1116-1123.
Haynes RB, T. D. (2012). Compliance in health care. Baltimore: Johns Hopkins University Press.
Horne R, W. J. (2007). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res, pp. 555–567.
Joan N Kalyango, E. O. ( 2008). Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr Health Sci. volume 8 Num.2, pp. 67–73.
Larme A, P. J. (2011). Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care volume21, pp. 1391-1396.
M, H. (2009). Non-communicable diseases, Community Medicine and Public Health, 6th ed. Karachi: Time Publisher.
McDonald HP, G. A. (2011). Intervention to enhance patient adherence to medication. JAMA, pp. 2868-2879.
Meichenbaum D, T. D. (2013). Facilitating Treatment Adherence: A Practitioner's Guide-book. New York: Plenum Press.
Odegard PS, C. K., & D, F. (2007). Medication taking and diabetes: a systematic review of the literature. Diabetes Educ VOL 33 Num.6, pp.1014-1029.
Ohene Buabeng K, M. L.-R. (2008). Unaffordable drug prices: the major cause of noncompliance with diabetic medication in Ghana. J Pharm Sci vol.7 Numr3, pp. 350–352.
Osterberg L, B. T. (2007). Adherence to medication. N Engl J Med, pp. 487-497.
Paes AHP, B. A.-A. (2007). Impact of dosage frequency on patient compliance. Diabetes Care 20, pp. 1512-1517.
Peyrot M, R. R. (2010). Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med, pp. 1379-1385.
Rollnick S, M. P. (2013). Health Behavior Change: A Guide for Practitioners. Edinburgh, U.K: Churchill Livingstone.
Simpson SH, E. D. (2008). A meta-analysis of the association between adherence to drug therapy and mortality. BMJ vol 15, pp. 333-7557.
US Dept of Health and Human Services. (2008, November 15). Retrieved May 10, 2014, from US Dept of Health and Human Services Web site: http://www.health.gov/communication/literacy/issuebrief/
Winkler A, T. A. (2010). Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly vol 44, pp. 34-99.
World Health Organization. (2010). besity: preventing and managing the global epidemic. Technical Report Series No. 894. Geneva: WHO.